Psychological distress, killer lymphocytes and disease severity in HIV/AIDS

Brain, Behavior, and Immunity

Volumn 22, Issue 6, 2008, Pages 901-911

  Greeson, Jeffrey M ^a   Hurwitz, Barry E ^a,b,c   Llabre, Maria M ^a,b   Schneiderman, Neil ^a,b,c,d   Penedo, Frank J ^a,b,d   Klimas, Nancy G ^b,c,e  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anxiety; Cytotoxic T cell activation; Depression; Distress; Helper T cell; HIV AIDS; Natural killer cell; Viral load

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL ACTIVATION; CELL COUNT; CYTOKINE PRODUCTION; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; STRUCTURAL EQUATION MODELING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANXIETY DISORDERS; CD8-POSITIVE T-LYMPHOCYTES; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES, HELPER-INDUCER; VIRAL LOAD;

EID: 46049083786     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2008.01.001     Document Type: Article

References (76)

1. Beck A.T., Ward C.H., Medelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
2. Black P.H. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav. Immun. 16 (2002) 622-653
3. Black P.H. The HIV seropositive state and progression to AIDS: an overview of factors promoting progression. N. Engl. J. Public Policy 4 (1988) 97-107
4. Brabers N.A., and Nonnett H.S. Role of the pro-inflammatory cytokines TNF-alpha and IL-1 beta in HIV-associated dementia. Eur. J. Clin. Investig. 36 (2006) 447-458
5. Breen E.C. Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immune deficiency syndrome. Pharmacol. Ther. 95 (2002) 295-304
6. Brownley K.A., Milanovich J.R., Motivala S.J., Schneiderman N., Fillion L., Graves J.A., Klimas N.G., Fletcher M.A., and Hurwitz B.E. Autonomic and cardiovascular function in HIV spectrum disease: early indications of cardiac pathophysiology. Clin. Auton. Res. 11 (2001) 319-326
7. Carrico A.W., Ironson G., Antoni M.H., Lechner S.C., Duran R.E., Kumar M., and Schneiderman N. A path model of the effects of spirituality on depressive symptoms and 24-h urinary-free cortisol in HIV-positive persons. J. Psychosom. Res. 61 (2006) 51-58
8. Centers for Disease Control and Prevention, 2005. HIV/AIDS surveillance report, 2004. US Department of Health and Human Services, Atlanta, GA, vol. 16, CDC. Available from: .
9. Centers for Disease Control and Prevention, 1992. 1993 revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 41 (RR-17), 1-19.
10. Chesney M.A., Ickovics J.R., Chambers D.B., Gifford A.L., Neidig J., Zwickl B., and Wu A.W. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 12 (2000) 255-266
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. (1988), Academic Press, New York, NY
12. Cohen S., Kamarck T., and Mermelstein R. A global measure of perceived stress. J. Health Social Behav. 24 (1983) 385-396
13. Cole S.W., Kemeny M.E., Fahey J.L., Zack J.A., and Naliboff B.D. Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system. Biol. Psychiatry 54 (2003) 1444-1456
14. Cole S.W., and Kemeny M.E. Psychosocial influences on the progression of HIV infection. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology. 3rd ed. vol. 2 (2001), Academic Press, San Diego, CA 583-612
15. Cole S.W., Naliboff B.D., Kemeny M.E., Griswold M.P., and Fahey J.L. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc. Natl. Acad. Sci. USA 98 (2001) 12695-12700
16. Cole S.W., Korin Y.D., Fahey J.L., and Zack J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 161 (1998) 610-616
17. Cole S.W., Kemeny M.E., Taylor S.E., Visscher B.R., and Fahey J.L. Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosom. Med. 58 (1996) 219-231
18. Collado-Hidalgo A., Sung C., and Cole S. Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication. Brain Behav. Immun. 20 (2006) 552-563
19. Cook J.A., Grey D., Burke J., Cohen M.H., Gurtman A.C., Richardson J.L., et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am. J. Public Health 94 (2004) 1133-1140
20. Dines I., Rumjanek V.M., and Persechini P.M. What is going on with natural killer cells in HIV infection?. Int. Arch. Allergy Immunol. 133 (2004) 330-339
21. Enders C.K., and Bandalos D.L. The relative performance of full information maximum likelihood estimation for missing data in structural equation models. Struct. Equation Model. 8 (2001) 430-457
22. Evans D.L., Ten Have T.R., Douglas S.D., Gettes D.R., Morrison M., Chiappini M.S., et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am. J. Psychiatry 159 (2002) 1752-1759
23. Fletcher M.A., Baron G.C., Ashman M.R., Fischl M.A., and Klimas N.G. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diag. Clin. Immunol. 5 (1987) 69-81
24. Florida Division of Disease Control. Quarterly Surveillance Report: Bureau of HIV/AIDS. March 2002, Number 211. Available from:
25. Folstein M., Folstein S.E., and McHugh P. Mini-mental status exam: a practical method for grading the cognitive state of patients for clinicians. J. Psychiatry Res. 12 (1975) 189-198
26. Fortis C., and Poli G. Dendritic cells and natural killer cells in the pathogenesis of HIV infection. Immunol. Res. 33 (2005) 1-21
27. Gallego L., Gordillo V., and Catalan J. Psychiatric and psychological disorders associated to HIV infection. AIDS Rev. 2 (2000) 48-60
28. Gandhi R.T., and Walker B.D. Immunologic control of HIV-1. Ann. Rev. Med. 53 (2002) 149-172
29. Giorgi J.V., Lyles R.H., Matud J.L., Yamashita T.E., Mellors J.L., and Hutlin L.E. Predictive value of immunologic and virologic markers after long or short duration of HIV-infection. J. Acquir. Immune Defic. Syndr. 29 (2002) 346-355
30. + T cell levels: results of 6 years of follow-up. J. Acquir. Immune Defic. Syndr. 6 (1993) 904-912
31. Gonzalez J.S., Penedo F.J., Llabre M.M., Duran R.E., Antoni M.A., Schneiderman N., et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann. Behav. Med. 34 (2007) 45-55
32. Green S.B., and Babyak M.A. Control of type I errors with multiple tests of constraints in structural equation modeling. Multivar. Behav. Res. 32 (1997) 39-51
33. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995) 123-126
34. Horowitz M., Wilner N., and Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom. Med. 41 (1979) 209-218
35. Hu L., and Bentler P.M. Cutoff criteria for fit indices in covariance structure analysis. Struct. Equation Model. 6 (1999) 1-55
36. Hurwitz B.E., Klaus J.R., Llabre M.M., Gonzalez A., Lawrence P.J., Maher K.J., Greeson J.M., Baum M.K., Shor-Posner G., Skyler J.S., and Schneiderman N. Suppression of Human Immunodeficiency Virus Type 1 viral load with selenium supplementation: a randomized controlled trial. Arch. Int. Med. 167 (2007) 148-154
37. Hurwitz B.E., Brownley K.A., Motivala S.J., Milanovich J.R., Kibler J.L., Fillion L., LeBlanc W.G., Kumar M., Klimas N.G., Fletcher M.A., and Schneiderman N. Sympathoimmune anomalies underlying the response to stressful challenge in Human Immunodeficiency Virus spectrum disease. Psychosom. Med. 67 (2005) 798-806
38. Ickovics J.R., Hamburger M.E., Vlahov D., Schoenbaum E.E., Schuman P., Boland R.J., et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA 285 (2001) 1466-1474
39. Ironson G., Balbin E., Stuetzle R., Fletcher M.A., O'Cleirigh C., Laurenceau J.P., et al. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Int. J. Behav. Med. 12 (2005) 86-97
40. Ironson G., O'Cleirigh C., Fletcher M.A., Laurenceau J.P., Balbin E., Klimas N., et al. Psychosocial factors predict CD4 and viral load chance in men and women with human immunodeficiency virus in the era of highly active antiretroviral therapy. Psychosom. Med. 67 (2005) 1013-1021
41. Kemeny M.E. An interdisciplinary research model to investigate psychosocial cofactors in disease: application to HIV-1 pathogenesis. Brain Behav. Immun. 17 Suppl. 1 (2003) S62-S72
42. Kline R.B. Principles and Practice of Structural Equation Modeling. 2nd ed. (2005), The Guilford Press, New York
43. Kopnisky K.L., Stoff D.M., and Rausch D.M. Workshop report the effects of psychological variables on the progression of HIV-1 disease. Brain Behav. Immun. 18 (2004) 246-261
44. Kottilil S., Chun T.-W., Moir S., Liu S., McLaughlin M., Hallahan C.W., et al. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J. Infect. Dis. 187 (2003) 1038-1045
45. Leserman J. The effects of stressful life events, coping, and cortisol on HIV infection. CNS Spect. 8 (2003) 25-30
46. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol. Psychiatry 54 (2003) 295-306
47. Leserman J., Petitto J.M., Gu H., Gaynes B.N., Barroso J., Golden R.N., Perkins D.O., Folds J.D., and Evans D.L. Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychol. Med. 32 (2002) 1059-1073
48. Levy J.A., Scott I., and Mackewicz C. Protection from HIV/AIDS: the importance of innate immunity. Clin. Immunol. 108 (2003) 167-174
49. Levy S.M., Herberman R.B., Simons A., Whiteside T.L., Lee J., McDonald R., and Beadle M. Persistently low natural killer cell activity in normal adults: immunological, hormonal, and mood correlates. Nat. Immun. Cell Growth Regul. 8 (1989) 173-186
50. Llabre M.M., Weaver K.E., Duran R.E., Antoni M.H., McPherson-Baker S., and Schneiderman N. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Care STDs 20 (2006) 701-711
51. Madden K.S. Catecholamines, sympathetic innervation, and immunity. Brain Behav. Immun. 17 Suppl. 1 (2003) S5-S10
52. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H., Dhabhar F.S., et al. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 23 (1997) 79-133
53. Motivala S.J., Hurwitz B.E., Llabre M.M., Klimas N.G., Fletcher M.A., Antoni M.H., et al. Psychological distress is associated with decreased memory helper T-cell and B-cell counts in pre-AIDS HIV seropositive men and women but only in those with low viral load. Psychosom. Med. 65 (2003) 627-635
54. Nair M.P., and Schwartz S.A. Synergistic effect of cortisol and HIV-1 envelope peptide on the NK activities of normal lymphocytes. Brain Behav. Immun. 9 (1995) 20-30
55. Nance D.M., and Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav. Immun. 21 (2007) 736-745
56. Oliva A., Kinter A.L., Vaccarezza M., Rubbert A., Catanzaro A., Moir S., et al. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Investig. 102 (1998) 223-231
57. Padgett D.A., and Glaser R. How stress influences the immune response. Trends Immunol. 24 (2003) 444-448
58. Penedo F.J., Gonzalez J.S., Davis C., Dahn J., Antoni M.H., and Ironson G. Coping and psychological distress among symptomatic HIV+ men who have sex with men. Ann. Behav. Med. 25 (2003) 203-213
59. Prado G., Feaster D.J., Schwartz S.J., Pratt I.A., Smith L., and Szapocznik J. Religious involvement, coping, social support, and psychological distress in HIV-seropositive African American mothers. AIDS Behav. 8 (2004) 221-235
60. Reed G.M., Kemeny M.E., Taylor S.E., and Visscher B.R. Negative HIV-specific expectancies and AIDS-related bereavement as predictors of symptom onset in asymptomatic HIV seropositive gay men. Health Psychol. 18 (1999) 354-363
61. Savarino A., Bottarel F., Malavasi F., and Dianzani U. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?. AIDS 14 (2000) 1079-1089
62. Schneiderman N., Antoni M., Ironson G., Klimas N., Hurwitz B.E., Kumar M., LaPerriere A., Brownley K., and Fletcher M.A. Psychoneuroimmunology and HIV/AIDS. In: Schedlowski M., and Tewes U. (Eds). Psychoneuroimmunology: An Interdisciplinary Introduction (1999), Kluwer, Academic/Plenum, New York 487-507
63. Segerstrom S.C., and Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130 (2004) 601-630
64. Sloan E., Collado-Hidalgo A., and Cole S. Psychobiology of HIV infection. In: Ader R. (Ed). Psychoneuroimmunology. 4th ed. vol. 2 (2007), Elsevier, Academic Press, San Diego, CA 1053-1076
65. Solano L., Costa M., Temoshok L., Salvati S., Coda R., Aiuti F., Di Sora F., D'Offizi G., Figa-Talamanca L., Mezzaroma I., Montella F., and Bertini M. An emotionally inexpressive (Type C) coping style influences HIV disease progression at six and twelve month follow-ups. Psychol. Health 17 (2002) 641-655
66. Sousa A.E., Carneiero J., Meier-Schellersheim M., Grossman Z., and Victorino R.M.M. CD4 depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169 (2002) 3400-3406
67. Spitzer R., Williams J.B., Gibbon M., and First M. Structured Clinical Interview for DSM-III-R: Non-Patient Version for HIV Studies (SCID-NP-HIV) (1988), New York Psychiatric Institute, Biometrics Research Department, New York
68. Suarez E.C., Boyle S.H., Lewis J.G., Hall R.P., and Young K.H. Increases in stimulated secretion of proinflammatory cytokines by blood monocytes following arousal of negative affect: the role of insulin resistance as moderator. Brain Behav. Immun. 20 (2006) 331-338
69. Suarez E.C., Krishnan R.R., and Lewis J.G. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom. Med. 65 (2003) 362-368
70. Swanson B., Zeller J.M., and Spear G.T. Cortisol upregulates HIV p24 antigen production in cultured human monocyte-derived macrophages. Journal Assoc. Nurses AIDS Care 9 (1998) 78-83
71. Temoshok L., Garzino-Demo A., Wald R., Sun L., and Wiley J. Replication of significant relationship between MIP-1β production following p24 stimulation and Type C coping. Retrovirology 2 Suppl. 1 (2005) P114 10.1186/1742-4690-2-S1-P11
72. Temoshok L., Wald R.L., Waldstein S.R., and Wiley J. Preliminary evidence for parallel dysregulation across coping, immune, and physiological response systems in patients from an HIV primary care clinic [Abstract]. Psychosom. Med. 68 (2006) A-20
73. Ullum H., Cozzi Lepri A., Aladdin H., Katzenstein T., Victor J., Phillips A.N., et al. Natural immunity and HIV disease progression. AIDS 13 (1999) 557-563
74. Vergis E.N., and Mellors J.W. Natural history of HIV-1 infection. Infect. Dis. Clin. North Am. 14 (2000) 809-825 v-vi.
75. Weaver K.W., Llabre M.M., Duran R.E., Antoni M.H., Ironson G., Penedo F.J., and Schneiderman N. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol. 24 (2005) 385-392
76. Whiteside T.L., and Herberman R.B. Role of human natural killer cells in health and disease. Clin. Diag. Lab. Immunol. 1 (1994) 125-133